Frank Dittmer

Neither type of mannose 6-phosphate receptor is sufficient for targeting of lysosomal enzymes along intracellular routes.

Dagmar Kasper, Frank Dittmer, Kurt Von Figura et al. · The Journal of Cell Biology · 1996 · 119 citations · Full text

Secretion-recapture Pathway, Protein Secretion, Genetics +21

Alternative mechanisms for trafficking of lysosomal enzymes in mannose 6-phosphate receptor-deficient mice are cell type-specific

Frank Dittmer, Eva Ulbrich, Angela Hafner et al. · Journal of Cell Science · 1999 · 114 citations

Alternative Mechanisms, Immunology, Molecular Biology +19

Preclinical Efficacy of the Auristatin-Based Antibody–Drug Conjugate BAY 1187982 for the Treatment of FGFR2-Positive Solid Tumors

Anette Sommer, Charlotte Kopitz, Christoph A. Schatz et al. · Cancer Research · 2016 · 73 citations

Pathology, Tumor Biology, Preclinical Efficacy +16

Allosteric Inhibition as a New Mode of Action for BAY 1213790, a Neutralizing Antibody Targeting the Activated Form of Coagulation Factor XI

Martina Schaefer, Anja Buchmueller, Frank Dittmer et al. · Journal of Molecular Biology · 2019 · 60 citations · Full text

Allosteric Inhibition, Immunology, Coagulation Factor Xi +23

Preclinical Antitumor Efficacy of BAY 1129980—a Novel Auristatin-Based Anti-C4.4A (LYPD3) Antibody–Drug Conjugate for the Treatment of Non–Small Cell Lung Cancer

Jörg Willuda, Lars Lindén, Hans‐Georg Lerchen et al. · Molecular Cancer Therapeutics · 2017 · 45 citations